Pharmac backtracks on plan to fund lung cancer drug Keytruda
The move has dashed hopes that Keytruda would soon be publicly funded for lung cancer - New Zealand's biggest cancer killer. RNZ has obtained documents showing Pharmac had planned to offer a Request for Proposals, or RFP, where drug companies are asked to pitch their products and prices, but has put that on hold due to budget constraints. Chief executive Sarah Fitt told RNZ that Pharmac was concerned about rising drug prices worldwide in the Covid-19 pandemic and that it could not commit to funding the drug now - but still hoped to in the future.
Lung cancer patients and their advocates are devastated and said they had been given false hope. Keytruda is available in New Zealand but patients must fund it themselves. "So what we now have is 30 lung cancer patients continuing to die prematurely every week and you have to ask yourself, is that acceptable?" Fitt said funding a drug like Keytruda for lung cancer would have cost hundreds of millions over the next five years and Pharmac could not commit to that given the Covid-19 outbreak.
========================================================
Today’s Mind-Bender is the Last of the Year! Can You Guess It Before Everyone Else? 🌟🎁🌲
I dance in the sky with green and gold, a spectacle few are lucky to behold; I’m best seen in the south, a celestial sight—what am I, lighting up the New Zealand night?
Do you think you know the answer? Simply 'Like' this post and we'll post the answer in the comments below at 2pm on the day!
Want to stop seeing these in your newsfeed? No worries! Simply head here and click once on the Following button.
No gift? No stress
Let the Christmas elves at Mags4gifts.co.nz handle your last-minute shopping. For a limited time, gift a subscription with up to 40% off best-sellers like TV Guide, NZ House & Garden, and NZ Gardener. It’s the perfect Christmas present, sorted in minutes (and no one needs to know it was a last-minute surprise)!
Loading…